Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Serstech AB's Enterprise Value for the quarter that ended in Jun. 2026 was kr119.77 Mil.
Serstech AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-27.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Serstech AB EV-to-EBIT Related Terms
Serstech AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Serstech AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Serstech AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Serstech AB EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Serstech AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Serstech AB's EV-to-EBIT falls into.
Serstech AB's current Enterprise Value is kr131.47 Mil.
Serstech AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-27.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Serstech AB (OSTO:SERT) has a EV-to-EBIT of -4.77 as of Aug. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Serstech AB and its competitors. According to the industry distribution chart, Serstech AB ranks #999999 out of 1243 companies in the Chemicals industry.
Is Serstech AB's EV-to-EBIT too high?
Serstech AB's current EV-to-EBIT is -4.77. Based on the distribution chart, Serstech AB ranks #999999 out of 1243 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Serstech AB has a GF Score™ of 33/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Serstech AB's EV-to-EBIT compare to DOW?
According to the Chemicals industry distribution chart, Serstech AB ranks #999999 out of 1243 companies for EV-to-EBIT. This places Serstech AB in the lower half of its industry. The industry median EV-to-EBIT is 17.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.59, based on 1,243 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Serstech AB and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Serstech AB's current EV-to-EBIT is -4.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Serstech AB stock overvalued right now?
Based on GuruFocus' analysis, Serstech AB (OSTO:SERT) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.40, compared to a current price of kr0.49 — trading 23.5% above its estimated fair value. The current EV-to-EBIT is -4.77. Serstech AB's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Serstech AB (OSTO:SERT), the current EV-to-EBIT is -4.77 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Serstech AB (OSTO:SERT) Overvalued in 2026?
Based on GuruFocus' analysis, Serstech AB stock appears to be overvalued.
The current stock price of kr0.49 is trading 23.5% above its estimated GF Value™ of kr0.40.
GuruFocus considers Serstech AB to be Modestly Overvalued.
Key valuation signals for OSTO:SERT:
EV-to-EBIT: -4.77
GF Value™: kr0.40 vs. price of kr0.49 (23.5% above fair value)
No single metric tells the full story. See the OSTO:SERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Serstech AB is engaged in chemical related products which help in the measurement and identification of chemicals. It offers Handheld Raman Spectrometer; Chemdash, Management and Reporting Software and Validated Data-Enriched and Complete Libraries. The company's solutions are used in the pharmaceutical production industry.
33GF Score
Get the complete analysis for OSTO:SERT
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SERT has been successfully added to your 
